scholarly article | Q13442814 |
P2093 | author name string | Dingjun Zhu | |
Fengjin Zhao | |||
Jinli Han | |||
Wenlian Xie | |||
Zaosong Zheng | |||
Haicheng Chen | |||
Yuhong Cai | |||
P2860 | cites work | Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 |
Posttranscriptional gene regulation by long noncoding RNA | Q26853608 | ||
Global cancer statistics, 2012 | Q27860501 | ||
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 | Q27860674 | ||
Cell-cycle checkpoints and cancer | Q28293996 | ||
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets | Q28396388 | ||
Long noncoding RNAs: functional surprises from the RNA world | Q29615826 | ||
TANRIC: An Interactive Open Platform to Explore the Function of lncRNAs in Cancer | Q30488162 | ||
LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma | Q34431243 | ||
Genetic evidence for functional dependency of p18Ink4c on Cdk4. | Q35663680 | ||
Metastasis markers in bladder cancer: a review of the literature and clinical considerations | Q35860967 | ||
The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis | Q36186374 | ||
CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer | Q36515055 | ||
Long noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO. | Q37520492 | ||
Bladder cancer in 2010: how far have we come? | Q37766697 | ||
Long noncoding RNA in prostate, bladder, and kidney cancer. | Q38174327 | ||
Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity | Q38297729 | ||
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature | Q38364643 | ||
The long noncoding RNA lncTCF7 promotes self-renewal of human liver cancer stem cells through activation of Wnt signaling | Q38427302 | ||
The emerging role of lncRNAs in cancer | Q38626016 | ||
The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation | Q38927720 | ||
Long noncoding RNA GAPLINC regulates CD44-dependent cell invasiveness and associates with poor prognosis of gastric cancer | Q38951043 | ||
Role of E2F3 expression in modulating cellular proliferation rate in human bladder and prostate cancer cells | Q40243680 | ||
Overexpression of the Long Non-coding RNA SChLAP1 Independently Predicts Lethal Prostate Cancer | Q41004851 | ||
Hypoxia Promotes Gastric Cancer Malignancy Partly through the HIF-1α Dependent Transcriptional Activation of the Long Non-coding RNA GAPLINC. | Q41188373 | ||
Hepatitis B virus X protein (HBx)-related long noncoding RNA (lncRNA) down-regulated expression by HBx (Dreh) inhibits hepatocellular carcinoma metastasis by targeting the intermediate filament protein vimentin | Q45353493 | ||
Updates in the Eighth Edition of the Tumor-Node-Metastasis Staging Classification for Urologic Cancers | Q48519380 | ||
Bladder cancer | Q87757090 | ||
A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma | Q87757619 | ||
P433 | issue | 5 | |
P304 | page(s) | 6770-6776 | |
P577 | publication date | 2018-03-02 | |
P1433 | published in | Oncology Letters | Q20640514 |
P1476 | title | Upregulated GAPLINC predicts a poor prognosis in bladder cancer patients and promotes tumor proliferation and invasion. | |
P478 | volume | 15 |
Search more.